Natalie Sacks, Chief Medical Officer at Harpoon Therapeutics, Inc. (HARP), sold 35,504 shares at $13.33 ($474K) on 2019-11-18, disclosed to the SEC on 2019-11-19.
Open-market sale of $474k HARP by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.33 | 17,252 | $230K | 48.5% |
| 2 | $13.33 | 17,252 | $230K | 48.5% |
| 3 | $14.00 | 1,000 | $14K | 3.0% |
| Total | $13.35 avg | 35,504 | $474K | 100% |
| Filing → |
| HARP | SELL | 2020-04-17 | $18K | — | Filing → |
| HARP | SELL | 2020-04-15 | $110K | — | Filing → |
| HARP | SELL | 2020-04-08 | $15K | — | Filing → |